The weekly litigation news digest is live. Subscribe now

IP Verse

Small Liposomes For Delivery Of Immunogen-Encoding Rna - EP4008357

The patent EP4008357 was granted to Glaxosmithkline on Dec 28, 2022. The application was filed on Aug 31, 2011 under application number EP21208092A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4008357

GLAXOSMITHKLINE
Application Number
EP21208092A
Filing Date
Aug 31, 2011
Status
Granted And Under Opposition
Nov 25, 2022
Publication Date
Dec 28, 2022
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
HOPFNERSep 28, 2023-ADMISSIBLE
JG OPPOSITIONSSep 28, 2023MEWBURN ELLISADMISSIBLE
WEICKMANN & WEICKMANNSep 27, 2023-ADMISSIBLE
SANOFISep 22, 2023ELKINGTON AND FIFEADMISSIBLE

Patent Citations (25) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONWO2011057020
OPPOSITIONEP4008357
OPPOSITIONEP4066856
OPPOSITIONWO02095023
OPPOSITIONWO2005120152
OPPOSITIONWO2005121348
OPPOSITIONWO2006078294
OPPOSITIONWO2007047749
OPPOSITIONWO2011005799
OPPOSITIONWO2011068810
OPPOSITIONWO2012006369
OPPOSITIONWO2012006376
OPPOSITIONWO2012006377
OPPOSITIONWO2012006378
OPPOSITIONWO2012030901
OPPOSITIONWO2014160243
OPPOSITIONWO2017075531
OPPOSITIONWO2022137133
OPPOSITIONWO9011092
SEARCHEP0786522
SEARCHEP1637144
SEARCHJP2007112768
SEARCHUS5750390
SEARCHUS5972704
SEARCHWO9952503

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents